Accelerate Diagnostics Inc
LSE:0H8E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Accelerate Diagnostics Inc
LSE:0H8E
|
US |
|
F
|
Fission Uranium Corp
F:2FU
|
CA |
|
NETGEAR Inc
NASDAQ:NTGR
|
US |
|
A
|
AXA SA
DUS:AXA
|
FR |
|
Banco Santander SA
MAD:SAN
|
ES |
|
United Therapeutics Corp
NASDAQ:UTHR
|
US |
|
Grupo Bimbo SAB de CV
OTC:GRBMF
|
MX |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0H8E's stock price target?
Not Available
0H8E does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Accelerate Diagnostics Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 1 year is 7%.